Ak Medical logo

Ak Medical(SEHK) 1789

Market CapHK$4.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+87%
5 Year-52%
1 Year-18%
1 Month-7%
HK$4.52
-0.88%
-0.04Today
Ak Medical last closing stock price
MetricPriceDate
Last closeHKD 4.522026-10-15
Ak Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.75%HKD 4.742026-10-08
1 month-7.48%HKD 4.882026-09-15
3 month-22.56%HKD 5.832026-07-17
Year to date-20.79%HKD 5.702025-12-31
1 year-17.76%HKD 5.492025-10-15
3 year-26.7%HKD 6.162023-10-16
5 year-51.61%HKD 9.332021-10-15
Since inception+87.17%HKD 2.432017-12-20

Ak Medical Financials at a Glance

Market Cap

HK$4.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥2.94B

Net Income (TTM)

CN¥670.48M

EPS (TTM)

HK$0.38

P/E Ratio

12.10

Dividend

HK$0.12

Beta (Volatility)

-0.04 (Low)

Price

HK$4.52

Volume

854,000

Open

HK$4.56

Previous Close

HK$4.56

Daily Range

HK$4.49 - HK$4.57

52-Week Range

HK$4.46 - HK$7.15

Estimated Earnings Date

Mar 31, 2027

1789 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ak Medical

AK Medical Holdings Limited is a leading enterprise specializing in the research, development, production, and global commercialization of orthopedic joint implants and related medical devices. Established in 2003 in Beijing, the company offers a diverse range of products, including conventional and advanced 3D-printed orthopedic solutions.

Products and Services
  • Conventional knee, hip, and spine replacement implants
  • Advanced 3D-printed orthopedic solutions
  • Distribution of third-party orthopedic products and surgical instruments
Growth Outlook
  • Strong demand for orthopedic implants is expected to drive revenue growth
  • Expansion into international markets enhances global presence
  • Investment in R&D supports innovation and product development
Financial Highlights
  • Recent quarterly revenue of 764.7 million CNY, reflecting robust sales
  • Net income margin of 25.7% indicates strong profitability
  • TTM P/E ratio of 11.89 suggests attractive valuation compared to industry peers
AK Medical Holdings Limited operates in the healthcare sector, focusing on orthopedic devices. The company has established a solid reputation for quality and innovation, which is reflected in its diverse product offerings. The recent quarterly financial performance demonstrates a strong revenue stream, with a notable net income margin that highlights effective cost management and operational efficiency. The growth outlook for AK Medical is promising, driven by increasing global demand for orthopedic solutions and the company's strategic initiatives to expand its market reach. Investments in research and development are expected to foster innovation, ensuring that the company remains competitive in a rapidly evolving industry. Financially, AK Medical has shown resilience, with a favorable P/E ratio indicating potential for growth relative to its earnings. The company's ability to maintain a strong net income margin further underscores its operational effectiveness. Overall, AK Medical Holdings Limited presents a compelling opportunity for investors interested in the healthcare and medical device sectors.
AI Generated • Oct 7, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

983

CEO

Zhi Jiang Li, MBA

Website

www.ak-medical.net

Headquarters

Beijing, BE 102299, CN

1789 Financials

Key Financial Metrics (TTM)

Gross Margin

62.75%

Operating Margin

27.49%

Net Income Margin

24.16%

Return on Equity

13.24%

Return on Capital

12.22%

Return on Assets

10.59%

Earnings Yield

8.26%

Dividend Yield

2.59%

Payout Ratio

19.30%

Stock Overview

Market Cap

HK$4.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.06B

Volume

854.00K

Avg. Volume

3.06M

Financials (TTM)

Gross Profit

CN¥1.79B

Operating Income

CN¥742.36M

EBITDA

CN¥961.00M

Operating Cash Flow

CN¥979.92M

Capital Expenditure

-CN¥234.00M

Free Cash Flow

CN¥745.92M

Cash & ST Invst.

CN¥1.25B

Total Debt

CN¥78.25M

Ak Medical Performance Analysis

Ak Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 1,223,402,51933.3%
20232023-12-31CNY 1,208,715,319-1.2%
20242024-12-31CNY 1,459,774,04420.8%
20252025-12-31CNY 1,607,739,74110.1%
Ak Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-314.1%
Q22025-06-300.7%
Q42025-12-3113.5%
Q22026-06-30-3.0%
Ak Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.21114.0%
20232023-12-31CNY 0.18-15.6%
20242024-12-31CNY 0.2747.7%
20252025-12-31CNY 0.3323.7%
Ak Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-7.7%
Q22025-06-3016.7%
Q42025-12-3114.3%
Q22026-06-3012.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥764.73M

+15.5%

Gross Profit

CN¥487.44M

+21.4%

Gross Margin

63.74%

N/A

Market Cap

HK$4.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$4.80M

N/A

Employees

1,004

N/A

Net Income

CN¥196.72M

+41.3%

EBITDA

CN¥277.88M

+43.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥1.25B

+65.1%

Total Debt

CN¥78.25M

-13.9%

Accounts Receivable

CN¥781.36M

+15.0%

Inventory

CN¥470.29M

-21.5%

Long Term Debt

CN¥8.50M

-81.7%

Short Term Debt

CN¥4.43M

-90.0%

Return on Assets

10.59%

N/A

Return on Invested Capital

15.11%

N/A

Free Cash Flow

CN¥131.24M

+695.1%

Operating Cash Flow

CN¥180.47M

+86.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About 1789

What is the current price of Ak Medical?

Ak Medical is trading at HK$4.52 per share.

What is the 52-week range for Ak Medical?

Over the past 52 weeks, Ak Medical has traded between HK$4.46 and HK$7.15.

How much debt does Ak Medical have?

As of the most recent reporting period, Ak Medical reported total debt of CN¥161.20M.

How much cash does Ak Medical have on hand?

Ak Medical reported CN¥684.07M in cash and cash equivalents in its most recent financial results.

What is Ak Medical’s dividend yield?

Ak Medical currently has a dividend yield of 2.59%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services